Updated:
Synteract
Synteract is a contract research organization (CRO) based in Morrisville, United States, founded in 1986. It offers full-service, Phase I-IV clinical trial...
Synteract
Synteract is a contract research organization (CRO) based in Morrisville, United States, founded in 1986. It offers full-service, Phase I-IV clinical trial services to biopharma companies. The firm has secured $3 million in total funding.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Carlsbad
Corporate office
Carlsbad, CA, United States
Frequently asked questions
Who runs Synteract, and what is its primary business?
No named principals or leadership team have been identified in public records for Synteract. The firm’s website registration points to a Carlsbad, California address, but its operational function—whether investment office, operating company, or other—remains unspecified.
Is Synteract a family office or asset manager?
The firm type is not publicly declared. Without disclosure of ownership structure or regulatory filings, it cannot be classified as a family office, asset manager, or other entity. Allocators would need direct confirmation from the firm.
What investment strategy does Synteract pursue?
No investment strategy, asset-class mix, or portfolio holdings have been publicly disclosed for Synteract. There are no known fund commitments, direct deals, or co-investment activities attributable to the firm.
Does Synteract have any verifiable deal flow or portfolio companies?
No portfolio companies, deals, or co-investment partners have been linked to Synteract in public sources. Any assessment of deal flow would require the firm to provide its track record directly.
Where does Synteract’s underlying wealth come from?
The origin of capital for Synteract is not disclosed. There is no public information about any family, individual, or institutional backer that funds the entity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: